20922 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals Plasma globulins, lactoglobulins
Haptoglobulin for Use in Treating or Preventing Exaggerated Erectile Response or Erectile Dysfunction
#2METHOD OF TREATING OR PREVENTING AN ADVERSE SECONDARY NEUROLOGICAL OUTCOME FOLLOWING A HAEMORRHAGIC STROKE
#3PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT
#4SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION
#5Cultured Thymus Tissue Transplantation Promotes Donor-Specific Tolerance to Allogeneic Solid Organ Transplants
#6PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT
#7SYSTEM AND METHOD FOR AGGREGATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS
#8SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS
#9HEMOGLOBIN-BASED OXYGEN CARRIERS AND METHODS OF MAKING AND USING THEREOF
#10SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS
#11GENE THERAPY FOR TREATING BETA-HEMOGLOBINOPATHIES
#12SYSTEM AND METHOD FOR ISOLATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS
#13Catechol Nanoparticle, Catechol Protein Nanoparticle, and Preparation Method and Use Thereof
#14SYSTEM AND METHOD FOR ISOLATING ALPHA 2M MOLECULES
#15METHODS FOR TREATING PLASMA PROTEIN IMBALANCES OR DEPLETION
#16METHOD FOR TREATMENT OF NERVE INJURY AND RELATED DISEASE
#17INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN
#18System and method for isolating alpha 2M molecules
#19ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH
#20Composition for boosting the immune system
#21HAPTOGLOBIN FOR USE IN TREATING AN ADVERSE SECONDARY NEUROLOGICAL OUTCOME FOLLOWING A HAEMORRHAGIC STROKE
#22BIFUNCTIONAL VECTORS ALLOWING BCL11A SILENCING AND EXPRESSION OF AN ANTI-SICKLING HBB AND USES THEREOF FOR GENE THERAPY OF B-HEMOGLOBINOPATHIES
#23AGENTS FOR TREATMENT OF ALCOHOL USE DISORDER
#24Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#25NUTRITIONAL COMPOSITION FOR INDUCING A FEELING OF SATIETY, A BETTER SLEEP AND/OR LIMITING NOCTURNAL AWAKING IN INFANTS OR YOUNG CHILDREN
#26Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease
#27NUTRITIONAL SUPPLEMENTS FOR ANIMAL HEALTH AND DEVELOPMENT
#28Native whey protein for treating and/or preventing intestinal infection
#29ApoC-II mimetic peptides
#30SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION
#31Animal plasma or fractions thereof for use in treating cognitive impairment disorders in humans and companion animals
#32VECTOR PRODUCTION IN SERUM FREE MEDIA
#33VITAMIN D BINDING PROTEIN IN THE CLINICAL MANAGEMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
#34BIOMARKER PANEL FOR MONITORING KIDNEY HEALTH
#35Method of reducing titers of antibodies specific for a therapeutic agent
#36Administration of serine protease inhibitors to the stomach
#37Methods of inducing liver regeneration by administering a plasma protein fraction
#38Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
#39USE OF ALPHA-1-MICROGLOBULIN FOR PROTECTION OF BONE MARROW CELLS
#40ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH
#41ApoC-II mimetic peptides
#42AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT
#43Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes cystatin, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same
#44Systems, compositions, and methods for transplantation
#45Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
#46Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#47Administration of serine protease inhibitors to the stomach
#48Treatment of ischemia reperfusion injury using alpha-2 macroglobulin
#49Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin
#50ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA
#51Systems, compositions, and methods for transplantation
#52Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
#53Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy
#54AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT
#55Method of reducing titers of antibodies specific for a therapeutic agent
#56Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptides in combination with probiotic
#57Method for reducing the inflammatory activity of a stem cell transplant and use thereof
#58Use of haptoglobin subunit for promoting wound healing
#59AUTISM-ASSOCIATED BIOMARKERS AND USES THEREOF
#60Functions of 55 Newfound Proteins and Their Medicinal Application in the Treatment and Prevention of Disease
#61SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION AND TREATING CONDITIONS
#62Administration of serine protease inhibitors to the stomach
#63Method of reducing titers of antibodies specific for a therapeutic agent
#64Systems, compositions, and methods for transplantation and treating conditions
#65PROTEIN-SPECIFIC FORMULATIONS
#66Invention
#67Method for reducing the inflammatory activity of a stem cell transplant and use thereof
#68Methods and compositions for detecting coagulation inhibitors
#69Sex hormone-binding globulin for use as a medicament
#70Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
#71AUTISM-ASSOCIATED BIOMARKERS AND USES THEREOF
#72Systems, compositions, and methods for transplantation
#73Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease
#74Systems, compositions, and methods for transplantation and treating conditions
#75METHODS FOR TREATING PROPERDIN-RELATED DISEASES OR DISORDERS
#76Method of reducing titers of antibodies specific for a therapeutic agent
#77Proteomic IPF markers
#78TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO
#79Compositions for masking the flavor of nutrients and methods for making same
#80Method of reducing titers of antibodies specific for a therapeutic agent
#81Synthetic synovial fluid compositions and methods for making the same
#82Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
#83Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
#84Treatment of conditions related to cecal ligation shock
#85METHOD FOR THE TREATMENT OF TYPE AND TYPE IV HYPERSENSITIVITY
#86COMPOSITION FOR PREVENTING AND/OR TREATING PEPTIC ULCERS
#87Method for the isolation of haptoglobin
#88Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders
#89Dairy components effective for fat loss